Akorn, Théa Pharma complete branded ophthalmic products saleMoving forward Akorn said it will invest in its facilities and targeted avenues of growth, such as its human generics and animal care businesses. Lannett to sell liquid drug manufacturing plant, other assets for $10.5MThe sale of Lannett’s liquid drug manufacturing facility in Carmel, N.Y., to a private company, is anticipated to close within the next several weeks. Glenmark obtains FDA OK for generic MetroGel-Vaginal gel MetroGel-Vaginal gel had a market value of approximately $60.4 million for the 12-month period ending November 2021, according to IQVIA. Xiromed, Genzum unveil generic Naftin The medication, a topical antifungal, is the generic of Naftin. Lupin launches generic Renagel The medication, which is the generic of Genzyme's Renagel, is used to treat hyperphosphatemia in patients with chronic kidney disease. FDA approves biosimilar Neupogen Releuko is the third biosimilar to Neupogen approved by the Food and Drug Administration, the company said. Viatris sells biosimilar assets to Biocon Biologics Viatris intends to continue to participate in the global biosimilars market through its ownership position in Biocon Biologics. TruPharma obtains FDA OK for generic Apokyn The Food and Drug Administration approved TruPharma’s apomorphine hydrochloride cartridges, the first generic of Apokyn. Camber debuts generic Epaned Camber’s enalapril maleate oral solution is indicated for the treatment of hypertension to lower blood pressure in adults and children age one month old and older. Ascend Labs, PursueCareRX establish patient preference referral program The program, designed to refer patients for dispensing of Ascend brand medications, is slated to launch in the first quarter of 2022. First Previous 91 92 93 94 95 Next Last
